i think cigna is happy and merck is happy. that's an exemplar to one approach to value-based pricing and pricing arrangements. >> steve, you all have been involved express scripts and other types of arrangements that have been discussed between payers and providers. give us a sense of how some of these others worked. one of you stressed indication-based outcomes. let's talk about that potential approach as well. >> one of the things we've announced is in 2016, we are actually going to introduce indication-based pricing for cancer products. and this was an idea that i stole from someone much smarter than myself, peter bach, from memorial sloan kettering. peter's been talking about this for a long time. what it essentially does is it recognizes that a drug is initially brought to the marketplace for one indication. let's take tarciva in lung cancer. it's a lung cancer agent. for the right patient, it can extend life by 5.2 months. for pancreatic cancer, it will extend your life for 12 days. now, the trouble for us as consumers i

.>>> the parents of alec merck spoke publicly today. he was passenger in a car crash that involved alcohol and speeding. >> you will only see it here on nine. we have been out in front on this story from the beginning. >> reporter: the parents were here to witness a guilty plea from kenneth salzman. he is the father who admitted to allowing underage drinking at a party in his home. six hours after his court appearance, kenneth salzman fled from our cameras. in court, he pled guilty to two counts of allowing underage drinking in his home. the judge gave him a maximum penalty, $2500 for each count. a total of $5000. >> i felt like he was just paying a parking fine, not paying for two lives.>> reporter: the two lives with her son and his friend, calton lead. both were passengers in a car driven by sam ellis that left the salzman party minutes before slamming into a tree and a fence. >> seriously injuring two, killing two, and putting the lives of more than two dozen at risk. the maryland law are really needs to change. >> reporter: there w

what we do at merck. that this drug has over prior therapies. what price will allow patients to have access and also, what value do we bring to the health care system and what will allow us to sustain the r & d to find the next important break through? so we try to optimize the prices and we don't think about maximizing prices. we think there's a reason to be socially responsible and take the long view. maria: if you've got a free market at least you'll have others in the market that will compete and also set prices. >> that's an important issue. i think that people look at the list price and talk about the list price. they don't see that the market actually incentivizes other people to bring competitive products to market. that's what we're doing in hepatitis c right now. bringing a good product to market that will compete with the market leader. maria: are you investing more in r & d in the coming here? >> yes, we think it's responsible for the company to drive that pipeline forward for society. maria:

merck has pled not guilty to two charges. he stared at the star throughout her testimony. she left the stand visibly upset escorted by deputies through a private exit. she told me, i was not prepared for how terrifying it was to see his face again. it shook me to my >>> m on, pitbull dishes out tasty details about performing at joe and sofia's wedding. >> that was a lot of fun. sofia knows how to have a good time. by the third song in, i did a 45-minute set. she was on stage with all her beautiful bridesmaids and friends and that's when the joe was on stage going oh, boy there's going to be a riot. >> mr. 305 is prepping his new year's revolution special hosting a beach bash on fox live from miami's bayfront park. >> half of the country will be snowed in, i want them to see that fire, that heat from miami through the television. brady. he steps into cindi lauper's "kinky boots" on broadway. >> he's a very good looking woman. i mean, he's a good looking man. lauper. wayne brady's a good looking woman. there's a little bit of lola in everybody. i like to speak out about bull

. >>> amgen and merck are teaming up to conduct two clinical trials.ests will evaluate a class of drugs that uses the body's immune system to fight cancer. amgen rose more than 4% to 161.43. merck was 2% higher to 53.64. >>> well, forget drones, for now anyway. amazon wants to deliver your packages the old-fashioned way. by truck. but they won't be using any old trucking company to get your packages where they need to go. morgan brennan takes a look at the company's new venture into the delivery game. >> reporter: amazon is going the extra mile, unveiling its new trucking fleet at an event in chicago earlier today. a fleet of thousands of branded semi trucks that will be used to haul goods between the e-commerce giant's warehouses, fulfillment centers and sorting hubs. the trailers or containers attached to the vehicles will be owned by amazon and transported by third-party operators that own their own tractors. the trucks will deliver orders around the country, and amazon says it's doing this to help fulfill demand since package volumes are "increasin

investors will be watching closely to see if merck offers a major discount to compete. investors hope the first month of the new year brings better news than the last six months of the old one. i'm meg terrell. >> did you ever wonder where all that money the movies make at the box office goes? we'll tell you who gets what and why it's so important. >> here's a look what to watch for on wednesday. housing once again grabs the headlines with two doo points. first with mortgage applications and then pending home sales for november. analysts are expecting a solid rise which is a good sign for housing activity. >>> and finally,ing with crude being a driver for stocks recently, investors will be keeping a close eye on oil inventories. >>> we told you last night that "star wars" the force awake ands was the fastest movie ever to reach the $1 billion mark. what does that mean and why is it significant? julia boorstin breaks down the box office economics. >> reporter: "star wars" the force awake ands record breaking box office is great for anyone with a piece of the business. bu

"merck"... which acquired the drug in -2- thousand -9-... for more than.... -40- billion dollars. the injectable medication helps patients recover... from the numbing effects... of certain surgical drugs. the f-d-a first rejected the drug.... in -2- thousand -8-... because of allergic reactions... and... some patients experiencing bleeding problems. we hope to see you again later tonight.... live at -11-. thank you for joining us. "inside edition" is next. tt2w`t3n@24" bt@qc., tt2w`t3n@24" "a@qs"h tt2w`t3n@24" bm@qx)d tt4w`t3n@24"" dztq k6$ tt4w`t3n@24"" entq ;2d tt4w`t3n@24"" gzt& "5< tt4w`t3n@24"" hnt& 2;p tt4w`t3n@24"" iztq xr( tt4w`t3n@24"" jntq j"h tt4w`t3n@24"" lzt& ro4 >>> the reviews s are in.

j & j, lily and merck. is this the right play? >> i'm already in them. you're asking the wrong guy. i'm in them, like them and like the price targets. j & j, $101 to $115. that is a strong move. >> price target on eli lilly is $95. price target on merck is $66. >> i think you'll have a tough time with drug stocks in a presidential election. lately, republicans and democrats are on the same side, prices are too high. may not be much friction there. there are going to be a lot of liquidations and redemption from health care hedge funds through the end of the year. now they're going to start selling. so i think you want to wait on it. i do still like the sector. just have to be very subsector specific. >> most view the name as best in breed. j & j, obviously. >> j & j is. i don't know if there is significant upside there. i think they do a lot better like gilead and amgen. >> joe? >> one thing that troubles me is interest rates and the talk about 100 basis points higher from where we sit today at this point next year. that's very complicated. very data dependent. don't play that game.

she told a los angeles county judge what happened the night she was allegedly by 45-year-old david merck. no cameras were allowed in the courtroom. her testimony was similar what she told me the morning after incident. >> i got attacked by a severely mentally ill homeless and he punched me in tface. clearly my face is a l swollen and my nose was red. he told me he was going kill me several times. and i absolutely believed him. murphy's pled not guilty through two charges. he stared at the star thr her testimony. she left the stand visibly upset. she told me, i was not prepared for how terrifying it was to see his faceagain. it shook me to my cor pitbull dished out tasty details about performing at joe a sofia's wedding. sofia knows how to have a good time. by the third song in, i did a 45-minute set. she was on stage with all her beautiful bridesmaids and friends, that's when the party joe was on stage going oh, boy, there's going to be a riot. >> mr. is prepping his new year's eve special hosting a beach b on fox live from miami's bayfront park. >> half of the country will snowed in, i

as you can see behind merck the story is still going on, state and local politician and passers by here at astoria walking by, stopping and listening to support this local man who has been here for more than two decade has five children, all attending schools in this area and owns this store here on the corner. at this very store saturday afternoon. noticed a man who was acting strange coming in. that man picked up a newspaper, referenced the san bernardino killings on the front of it and then allegedly said to m hook, "i kill muslims" before attacking him. he was arrested by aypd who are investigating this s a hate crimli lothcal politicians here today say th- ey believe we as a nation are at a c ossroads when it comes to deal g with re. >> mr. shook ahpill floor this community, here over two decades, as a small businessman, his children go our local schools and he has been so someone who we are proud to call aa neighbor and a friend. >> it's disgusting to me to think that somebody came into our community and committed this heinous crime and thought that that was okay. >> reporter: now

thank you so much to ken frazier, the ceo of merck for joining us. met with president obama recently to discuss this topic. you talked about it on your last quarterly earnings call. could you tell us about that conversation and how the government is thinking about this issue? >> well, it goes back a couple of months now. the conversation we were having was largely around tcp and the intellectual markets. >> what were his thoughts? what did he communicate to you about drug pricing and the issues that the government was considering? >> i will say that the president has always made it clear that our industry has to take a role in helping to contribute to a sustainable solution in terms of health care spending. we are eager to play that constructive role. >> it has become such an election issue. what is your anticipation will happen under a new president? >> well, i hope that people will look at, for example, the medicare, part "d" program and see that it has worked. it has come in at 45% below initial cost estimates. why does it work? because we rely on

merck may be hunting in cancer as well.hey have a lot of cash on the balance sheets. >> a political note talking about the continued resolution bill that may get funded and that 2% medical device tax may be delayed by a couple more years. that could be good for any companies like a j & j that make any kind of medical device. >> electronic, boston scientific and so on. >> bingo. >> next stock, yumm brands. upgrading to an outperform. i love this title. let's taco about business outside of china. >> of course you love it. of course you love that. >> taco about business. analyst says the shares offer a favorable risk-reward. they nudge the price target to $88. they see increased focus on the taco bell brand here. they note that business outside of china much more predictable than in china business. that implies 20% up side. >> there could be a valuation here. take a look at a winner like mcdonald's. yumm brand is up 2%. you know what the forward pes are? the same at 24. what are you paying for at this point? next up here, go p

is merck going to offer a discount to snap up market share? >> these are the events we see stocks thrown up in anticipation, even in just today's session. these are some pretty big moves that could be a bigger market moving events. >> you have already seen them move a lot. it's one of the biggest movers of the entire year, doubling on positive progress toward get ago principle of law. it will be interesting to see how the stock reacts to the drug. >> whether is the next big conference? because that tends to be the macro volatility generator in bioteches, when you go to the big conferences. >> yeah. the investor conference j.p. morgan comes out the second half. fwhut ter but in terms of clin calls, there is a lot in april in terms of conferences and there is more smaller ones. >> thank you. >> all right the overall, stocks are having a pretty good little year end run hitting session highs. the dow up is 200 points. look at the map right now. only one dow stock is down. that is "star wars" owner disney. apple, the biggest dow winner up more than

the current dogs of the dow include verizon, chevron, ge, mcdonald's, pfizer, merck, caterpillar, exxonmobil, coca-cola and proctor and gamble. mcdonald's and general electric have been two of the dow's best performers this year. meanwhile, ibm and walmart have lagged behind. so, as of now, next year's dogs would kick out the ge, mcdonald's and coke shares and add sysco, ibm and walmart. investors who use the strategy will be looking to see if some of the dogs can reverse this year's losses. for "nightly business report," i'm dominic chu. >>> well, as dominic just reported, walmart will be one of the dogs of the dow for 2016. it is also, by the way, the worst-performing stock in the blue chip index so far this year, down about 29%, as you see there. so, what's ahead for the big-box chain? tom lee is founder and head of his own research fund, fundstrat global advisers. good to see you. would you buy walmart at today's values, and how long do you expect you might need to wait to get paid if you would buy it? >> yes, i would definitely buy walmart today, because one, you know, it's an iconic co

normally, merck is a country country where it's kind of like a house. you never need to go consult the blueprint of the building, you just walk in the hallways and sit on the couch. this only when the building begins to shake that you say, i better go to the attic, i better figure out how this thing is put together. we are one of those times where it is in our hands, tragic necessity it is our mission to be in the position to save this country. think of all it has done for us and what we need to do now as we have the creativity and the resolution to put america back together again. thank you very much. [applause]. [inaudible] >> if you want to watch this program again, visit book to be.org to watch any of the programs you see here online. type the other name, or book table in the search bar at the top of the page and click the looking glass. you can can share any videos of the website by clicking facebook, twitter, or share icon at the bottom. book to be, since 1998, all of

merck is taking aim of the u.s. tax system. frazier says pfizer allergan deal signals the challenge is to stay competitive globally. >> the u.s. tax system is not competitive in a global sense. we have to come up with a tax system that allows u.s. companies to be in competition globally for talent, investors, ip assets and everything that makes this industry run. i think that deal should be something that serves notice to policymakers that good american companies feel no choice what to do things like tax inversions to remain competitive globally. alix: all seven major british banks have passed boe stress .ests two of the banks, standard chartered and royal bank of scotland fell short in at least one requirement. the commodities route continues to pose risks. the ceo of a de anza says prices are not at the bottom but there are factors that are emerging that make metals attractive to investors. >> everyone expecting interest rates to go up. the dollar is strong. chinese slowdown some oversupply and the uncertainty about when rate

johnson & johnson, eli lilly and merck all is higher. using these companies to beef up the drug pipeline instead of financially driven m&a is preferable. things like tax inversion for example. we have seen some high-profile ones of those as well. fairfield innovation will support feeling pricing. we will likely supersede drug pricing concerns on election season rhetoric. maybe some of that will die down. also wanted to look at some individual drag on the overall average. -- records and percent. credit suisse saying apple has been cutting in supplier orders and checks reconfirm that. finally, getting a downgrade to an underperform. just to be specific this is a fork engine maker industrial uses. the analyst at bank of america not optimistic on that market in the u.s.. thank you. let's check on the first word news. mark crumpton is at our news this with more. president obama trying to cool off the heated dispute between the president of russia and of turkey. his urging turkey and russia to focus on the common goal of fighting islamic state

shares of merck are also on the rise. bank stocks are in the green there.eld higher interest rates. theoretically higher interest rates. they would benefit from it. november auto sales. black friday commotion. started well before thanksgiving. nissan sales. 25%. intelligence report will be right back. whether or not done should be allowed in buildings. ♪ the pursuit of healthier. it begins from the second we're born. because, healthier doesn't happen all by itself. it needs to be earned every day. using wellness to keep away illness. and believing a single life can be made better by millions of others. as a health services and innovation company optum powers modern healthcare by connecting every part of it. so while the world keeps searching for healthier we're here to make healthier happen. >> i say this every time we have one of these mass shootings. it just doesn't happen in other countries. trish: president obama earlier today. outside a planned parenthood in colorado springs. he made that comment saying shootings do not happen in other countries. of al

the best-performing individual doing within health care, quite well, johnson & johnson, eli lilly, merck them rated by barclays. analysts saying that we should see, hopefully, according to the analyst, more investment acquisitions of more pipeline. new drugs rather than financially dragon -- financially driven m&a. drugs comingecific on these three companies and in terms of the consumer discretionary and tech combo here, facebook, amazon, netflix, amazon is trading at a record today. so are those alpha that shares. all of this momentum coming off the holiday weekend, shopping of course, disney rising within consumer discretionary today after fiscal 2017 for the company could see a profit increase of 35% for 2015 on a fiscal basis. wars is does star coming out this december, but the next one is coming up next december. saying that if you look at how people tend to do, that is where he is getting the modeling here for that earnings increase. up 1.5%. they're supposed to be a new one for every year for the next five years? you can never have enough. julie: i can. [laughter] betty: julie hym

i read every 17th century account of the new england merck of the howling wolves and the lurking native americans, but it took me a very long time to realize how dark dark chili can be. our world is utterly electrified in their world is physically black. in fact, it took me until-- this is downtown manhattan 2012, in the wake of hurrican sandy i was driving friends home when the power was out and i turned off the headlights and suddenly all of those accounts of the new england wilderness so we made sense to me. seventeenth century dark was a very different dark hence the line in chapter one, the sky over new england was crow black, pitch black, viable black, so black it could be difficult at night to keep to the path, so black a line of trees might freely migrate to another location. or that you might find yourself pursued after nightfall by a rabid black called leaving you to crawl home bloody and disoriented on all fours. i should mention also, court testimony the early american often mentioned he had been an ear witness to something. word and sound careened supreme. it was really rea

here procter & gamble and merck as well. can see these hefty dividend yields north of 3% or thereabouts. the other five that we have so far, at least in this year's list, verizon, coca-cola, pfizer, mcdonald's, and ge. now, i want you to kind of pay attention to what's happening here overall with some of the shares because overall with general electric and mcdonald's, we've seen some real share price appreciation. as a result those names go out of the dow -- dogs of the dow. the yelields are no longer high enough. >> this is where they began the year of 2015. >> now, let's take a look at the new ones. the ins and the outs. if we can see what they are. who has gone out? coca-cola, mcdonald's, and general electric all around 3% yields. if things were to end today, they would no longer be part of the dogs of the dow. instead they will be replaced by cisco, walmart, and ibm. all of those guys go into the overall dogs of the dow. so the idea here is if you rebalance, everything else pretty much stays the same except for these thr

that is after you take out the former ceo of merck, who got paid more than $20 million last year.etty: and how are they able to get away with that -- this is all disclose, right? meeb: what folks have told is before a bio pharma startup gets a big break, they have no cash. they have a promise. they load these guys up with options, and sometimes they make it big. at the top of the list of high-take board you have three bile from a company's. -- bio pharma companies. betty: why is it concentrated? caleb: specifically they are cash-poor and they had these directors that have been with them 10, 20 years, waiting for the big break. they do not have the cash to give them then, so they give them options. in this case, these three are making it big all of a sudden, and their directors are finally being rewarded handsomely. betty: are the shareholders now saying because they are compensated so well they cannot be good stewards for the shareholders? they can't be independent? there are some concerns that this is more than enough to be a person's sole bread and butter. can they come to the c

and merck, p & g and wal-mart among the biggest losers in the dow. have to be the biggest dividend payers in the group. the dogs of the dow for 2016. we'll debate that and, of course, lots more. scottie, back to you. >> followed -- anything to do with the home. that's been a bright spot. the stock is 2340u down 35% over the last we're. the consumer discretionary sector is up ten. a massive underperformer. i don't know why anyone would be in this name from a price action standpoint, scott. this stock has been below a downward trend for 15 day the entire year. there have been no reasons to be in this at all. >> you are feeling some pain today, my man. you own micron? >> i own some out of the money calls on micron, yes. i did. and took profits on half of those, judge. ahead of the earnings. the bottom line expectations would have kept the stock the way it was. the guidance is just terrible. guidance took it down, i think, 12 cent loss versus 5 cent expected, and they're going to miss by as much as 500 million on sales. >> anybody else have thoughts on t

rbc capital markets estimates that this decision for merck's drug to have a 5% stock impact on gileadwhat's going to be important to watch there of course we all know hepatitis c price is a big issue. they need to give a business dig count in order to get market share in this competitive space. >> mike, your take? >> it's been amazing to me you go through these periods where biotech trades as one block, despite the fact that all these different companies with different pros dekts that are red or green. are we in a mode where there's general skepticism toward each of these companies, toward the business model toward pricing? >> there's general skepticism across the industry but individual companies people feel differently about. it has been interesting to see the sentiment shift from, for example, there was a company zak jen, canceled out of conferences, normally in the beginning of year people think they have a big deal or data. the stock plunged just knowing that they scans ld out of presenting at some conferences. it did turn out to be negative information unfortunately and that's k

. >>> the merck also reports santa clara county will end the longstanding policy of accepting inmates from other county jails. since the year 2000 the county has had an agreement of taking in inmates from other counties. they will focus solely on the inmates they already have. the county cites an increase of inmates with mental health needs and the limited space available to house them. >>> republican candidates clashed in the final debate of the year. donald trump was the big talk for his ban on banning muslims entering the u.s. >> kris in the wake of the terror attack in san bernardino, national security taking center stage. >> almost all of it was about national security for the last debate of the year. one of the main headlines we want to highlight is trump is vowing to stick with the gop and not run as and independent. he also dominated six social media and six online polls. as you mentioned, this was the first debate since the terror attacks in paris and in san bernardino and the first since donald trump called for an all out ban on muslims in the united states. as you said, sam

their life and the ask companies to give something away that cost $1 billion to develop if you are merck is a of a drop in the bucket but the innovative treatments are coming out a small labs of 10 doctors and they don't have a lot of extra drug available. even though the willingness to part with it. those are real challenges. and they will need to be tackled. the system will let the perfect but it opens the door for right to try and getting the movement going. that is critical. >> host: you're talking to insurance companies about this possibility? >> have not spoken with insurance companies yet. but i have spoken with people who are working overseas with insurance companies and they're telling me they have a strong sense they will come to be helpful with this. it will take a little bit of time but it is interesting when you talk to the patients. it is a great theoretical discussion but the patients say don't let that be a barrier to my treatment. if i've told fund-raisers i will do that. real people's lives are at stake. said the insurance company is a real one but don't let that be a b

it's merck, xerox, ibm, et cetera. they were paying 60, 70 times earnings. opec increased the price of oil ten fold. we've gotten a serious recession. those stocks collapsed, and it took a decade for them to recover. okay? the stocks are going to get adversely impacted. the good news, however, we own my largest position is google. it's 20 times earnings. the market is very reasonably priced, and if we avoid recession, i think the average common stock will do better and catch up to what the leading stocks have done. >> so appreciative of you come on today making a lot of time for us on a take that could be historic really given the fact that the federal reserve has not hiked interest rates in nearly a decade. i know we'll talk to you soon. have a happy and healthy one. >> same to you. thanks for having me. thank you. >> leon cooperman of omega. >> slight gains as we count down to the fed decision. here is the sector heat map. led the day as is the s&p. utilities, telecom, and consumer staples. coming up, you heard from the stock guru. next we're joined by the

never confuse them with a merck or bristol myers but as long as first two for speculation with blueberg even though i can see why you might want to take a stab at calling a bottom. stick with cramer.but these liquid gels are new. mucinex fast max. it's the same difference. these are multi-symptom. well so are these. that one doesn't. uh...think fast! you dropped something. oh...i'll put it back on the shelf... new from mucinex fast max. the only cold and flu liquid gel that's max-strength and fights mucus. start the relief. ditch the misery. let's end this. i'm lucky to get through a shift without a disaster. my bargain detergent couldn't keep up. so i switched to tide pods. they're super concentrated so i get a better clean. 15% cleaning ingredients or 90%. don't pay for water, pay for clean. that's my tide. want to survive a crazy busy day? sfx: cell phone chimes start with a positive attitude... and positively radiant skin. aveeno positively radiantmoisturizer... with active naturals soy. >>> it is time. round! >> sell, sell, sell, sell, sell! >> are you ready, skee-daddy? time for t

his credit worked very hard to pass comprehensive immigration reform bill and in a republican pry merck really paying the price for that support. cruz of course opposed to this bill. >> you write about this and you say this is why, in the long run, cruz has the advantage in his three policy fights with rubio. >> my view of these fights in the republican primary is who has the position that is closest to president obama, right. and that's a bad place to be. so on two of these three issues we just outlined, nsa surveillance, interventionism and immigration, cruz is more aligned -- excuse me, marco rubio is more aligned with the obama position than cruz, he's to the left of where cruz is. and these are pretty important issues. the two where he's closer to obama of course are on immigration and on intervention. cruz, excuse me, rubio supported the intervention in libya, which is becoming very unpopular among republicans, because a lot of republicans, rightly, argue it's left the vacuum that isis has entered. i think rubio has done a good job muddying the waters in the last week over his pos

never confuse them with a merck or bristol myers but as long as you understand that, i bless the first speculation although i do have a harder time with blueberg even though i can see why you might want to take a stab at calling a bottom. stick with cramer. >>> it is time. time for the lightning round! >> sell, sell, sell, sell, sell! >> are you ready, skee-daddy? time for the lightning round. start with john in tennessee. john? >> caller: hey, hold or sale, medical properties? >> i'm not even going there. keep that one. glenn in new jersey. glenn, glenn, glenn. glenn? glenn? glenn in new jersey. >> caller: yes. i'm here. how you doing, jim? >> all right. you're up. >> caller: [ inaudible ] storage. >> i like the trade. it's okay down here at 13. how about sean in maryland. sean? >> caller: front line, fro. >> no, no. go with hanson. that's doing better. let's go to jimmy in arizona. >> caller: hi, jim. depo med. buy, sell or hold? >> we got turned off by depo med after horizon walked away. we will walk away with them. derek in alabama. derek? >> caller: roll, tide. my stock is active

it's the merck's national hiv campaign to empower people living with hiv to speak out and have a voice. >> and i understand the focus of this campaign is really to put people in charge of their own lives and their own cares, even when they talk with their doctors. it helps you to know what questions to ask, how to ask not only about the virus but some of the other opportunistic illnesses that come along with having the virus. >> and, you know, because we -- i'm a long-termer. that's what they call me. 20 years now. and so, my concerns have shifted into now i've been here 20 years, so my focus is not so and we just conducted a survey that also talked -- spoke to that, that people with hiv are now who are living 10 years or better, now their focus is their other health issues... >> yes. >> ...that come along. you know, i'm over 50. >> that come with the virus and the hiv. >> absolutely. so, i'm over 50. my concern is arthritis. my concern is menopause. you know, and other people's concerns are different, because, you know, hiv is not one set. it's not fit. it's differently for everyone.

there are bits of green on the screen from johnson & johnson to merck but they're few and far betweenan, jeannie wyatt, ceo of south texas money management made a prediction spot on. it wasn't just one. you called it. you said both the action this year would be very volatile and you gave the reason, it would be lower commodities. that was a year ago. you have been absolutely right. how did you know and how did you invest around that to make money for your clients? >> we really lamented our energy exposure. liz: we should show oil down below $38 a barrel. >> yes, yes. important psychological level. obviously in sympathy with the saudi news but perhaps we're closer now to finding a bottom. i'm not predicting that. oil prices are impossible but maybe 10 to 20% more downside but we're we have a lot of the bad news on the table. liz: okay. >> a lot of production starting to be shut in. liz: we like to see at least the bad news on the table. can i take a much shorter timeline here. past three trading sessions, we can put it up, at this exact time, go to thursday, we were -- we can show this

this is one that will basically be sitting and grinding because you have the merck approval coming, you have people worried about pricing and i think you have people worried about what the hep c numbers look like. until they do a meaningful deal, which i don't think they will do this year or unless something hits out of the pipeline, a drug for sorosis, i think that stock is just a grinder this year. >> michael, you mentioned the huge shift in flows. part of that is investors locking the gains over the last few years. but i'm sure part is the biotech taurus. are there a sense that people got burned by the sector and want to have nothing to do with it going into 2016. >> i think there is a little bit of biotech fatigue. that t has been three, four, five years of great performance. a lot of people have made money. a lot of people don't expect it to go up a lot this year. and some of that is rotation out into another things. one of the analysis we did when the mbi took a tumble in september was looking how the internet stocks, like the q. net and the btk had been trading in a range, as soo

cap health care getting a boost from barclays with high recommendations for j&j, it eli lilly, and merck will bolster their pipelines, which would be preferable to more tax and version. -- tax in version. n. tax inversio i also wanted to point out one individual stop doing well today and that is consol energy. in see the shares rising back-to-back sessions. no news today, but we have had analysts saying that some of the year's most battered stocks tend to do a little better this time of year and outperform as people come in and buy and it could last through february. ok, thank you so much, julie. let's check in on the first word news this morning. courtney donohoe has more from our news desk. courtney? president obama says that russia is starting to realize the price of backing syrian president the charla side is to hide. russians obama: the for severaler basel weeks, over a month. for weeks, over month. the situation has not changed significantly. courtney: the u.s. has not dropped its insistence that sad can play no role in syria for future. mr. obama says any deal to limit greenhouse

. >> reporter: the vaccine is made by merck. the trial is a partnership between the sierra leone ministry of health, the u.s. centers for disease control and prevention and the medical college in freetown. >> once we can document the effectiveness of the vaccine and we are now sure that it can really protect them, we can move to another stage where we look at the community and the population at large. >> reporter: across the border in liberia, a separate trial is testing the same vaccine, along with another one made by glaxo smith kline. it is open to all, and based at this hospital in monrovia. in the darkest days of the crisis here in liberia, a senior doctor and nurse here at redemption hospital contracted ebola virus disease and they subsequently died. many of the health care workers here became afraid to come to work and the hospital had to close for a time. in all 13 members of the hospital staff died here. >> it was scary. it was confusing >> reporter: dr. mark kieh is the site physician for the trial. so far, there are 1

always got to love that merck. i think these stocks are going higher.e the pharmas. >> seaburg? >> i like the pharma as well. bristol-myers. i like the pipeline here and like the stock. bristol-myers is a buyer. >> shout out to stock. >> my kids failed everything today. disney back on the trade again. >> guy adami? >> that was fantastic. >> a play officer. we play, laughs. >> grasso's kids. >> health care, health care. and i'm going to give you pfizer. >> wow. >> which means health care is going to get obliterated tomorrow. >> i'm melissa lee. thanks for watching. see you tomorrow here at 5:00 for more "fast." meantime, "mad money" with jim cramer starts right now. >>> my mission is simple. to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere. i promise to help you find it. "mad money" starts now. hey i'm cramer. welcome to "mad money." welcome to cramerica. other people want to make friends and i'm trying to make you money. my job is to teach and coach you. call me at 1-800-743-cnbc or tweet m

, exxon and free and as your leaders, merck is up 1.5%, exxon 1.7%, disney and 90 holdback, 90 came oute orders, beat expectations even in greater china doing well, stock hit an all-time record high but since pulled back and. those gains. under our and 19 never won the dow, and their armor, but smart, the new chief financial officer, that stock is 2%, a real winner year to date, 5:00 a.m. see it every day for breaking news. stuart: 16 minutes ago we got the news, big drawdown in supply, we aren't losing a lot of oil in the price is gone up $37.60. mining stocks are up. there is a report the somehow or other china will credits deal surplus. that is a surplus the kids yelled prices that decade lows, mining companies getting rid of that surplus. sand that replacing his reindeer with robots. >> something out of the nightmare before christmas. you won't get these robots any more calmly or lovable, this is boston dynamic, the google bought several years ago showing off robotic prowess. stuart: i like them. not for christmas but fair enough. google is teaming go with ford, they will build a se

. >> we spoke with chairman ceo of ebb merck ken frazier yesterday we talked about all the consolidation taxes, and why we're seeing so much change because companies are trying to -- get a better situation when it comes to taxes on there what he had to say want your take on tax reform. >> we need a tax code, that doesn't put u.s. companies out disadvantage lowering statutory rate also means perform going to a territorial system u.s. only vansed company wants to tax ex u.s. revenue as though taking place in u.s. companies like merck apple face double taxation penalty if they bring offshore cash to the united states. >> do you agree with that. >> i do, unfortunately i am one of those that manufacturers does everything in united states, so i am panhandled for that, i am competing against global companies that are far lower tax rates, that is one of the reasons it is cheaper to acquire a company in -- where is money going to come to build when taxes they stake 35% corporate earnings. >> when pfizer merges with allergan going to pay 14%, okay, because that is they are are in ireland that is l